Artrya

About Artrya

Artrya is a medical technology company that has developed an AI-powered solution for the diagnosis of coronary artery disease. The company's flagship product, Artrya Salix, uses artificial intelligence to analyze cardiac CT scans and provide a detailed report on the presence and extent of plaque, stenosis, and other disease indicators. This allows clinicians to make faster and more accurate diagnoses, leading to improved patient outcomes.

The company partners with hospitals and cardiac clinics to integrate its solution into their existing workflows. Artrya's business model is based on a fee-per-scan arrangement, which provides a recurring revenue stream. The company is headquartered in Perth, Australia, and has a growing presence in international markets.

Artrya's technology has the potential to revolutionize the way coronary artery disease is diagnosed and managed. By providing a more accurate and efficient solution, the company is well-positioned to capture a significant share of the growing cardiac imaging market.